ArticleCell death & disease2020

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells.

Nabanita Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.